PATALGARUDI FOR THE TRATMENT OF URINARY TRACT INFECTION

A COMPARITIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF PATALGARUDI DISPERSABLE TABLET IN THE MANAGEMENT OF LOWER URINARY TRACT INFECTION WITH NITROFURANTOIN - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056351

Enrollment

Registered

2023-08-09

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with LUTI Any of two or more symptoms described in the context of LUTI Patients irrespective of gender caste and religion Patient between the age group of 20 70 years

Exclusion criteria

Exclusion criteria: Below the 20 years or above 70 years Hematuria Renal failure Pyelonephritis Nephrotic syndrome Septicemia Chronic systemic illness uncontrolled DM and HTN HIV Malignancy HBsAg TB

Design outcomes

Primary

Measure	Time frame
WILL SUBSIDE THE SYMPTOMS OF URINARY TRACT INFECTIONTimepoint: 21 DAYS	—

Secondary

Measure	Time frame
WILL SUBSIDE THE SYMPTOMS OF LOWER URINARY TRACT INFECTION Dysuria Frequency of micturition Urgency FeverTimepoint: duration of treatment- 14 days follow up- every 7th day till 28 days	—

Countries

India

Contacts

Public ContactDR OM PRAKASH DAVE

PARUL INSTITUTE OF AYURVEDA

dr.omprakashdave@gmail.com9460770626

Outcome results